Under the new five-year agreement, Cana will manufacture 385,000 units of CERTORUN® (sertraline hydrochloride) over the ...
Inflation forever? The fear has taken root seemingly everywhere: the media, the bond market, the futures market.
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare ...
Company identifies real estate, digital assets, and marketable securities, among others, as potential sources of liquidity — with a combined ...
Europe’s leaders are waking up to the terrifying danger that China could obliterate much of their industrial base within less ...
Why has housing construction ground to a halt in DC? Market-rate and affordable development are both crashing — but not for ...
Although Arch Capital Group has underperformed its industry peers recently, analysts remain moderately optimistic about the ...
Chipotle Mexican Grill (CMG) is a California-based fast food chain restaurant operating in over 4,000 locations across the ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Strengthening proprietary IP portfolio and next-generation product development pipelineKEY HIGHLIGHTS Cana Laboratories, Cosmos Health's wholly owned subsidiary, acquires international patent applicat ...
Detailed price information for Cosmos Health Inc (COSM-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results